The DOI matches its Crossref record; 101 of the 102 references it cites were found in a registry or an index.
Cancer and the chemokine network
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CXCL1 and 2 are 90% identical by amino-acid sequence and signal through the same receptor CXCR2 (Balkwill, 2004).”
From A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis (2012) · cites this paper as Balkwill, 2004
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Self-citationInternational Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
Zlotnik, A., & Yoshie, O. (2000) · Immunity · doi:10.1016/s1074-7613(00)80165-x · Cited by 3,923
Tumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1256 · Cited by 3,413
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
Zhang, L., Conejo-Garcia, J. R., Katsaros, D., Gimotty, P. A., Massobrio, M., Regnani, G., Makrigiannakis, A., Gray, H., Schlienger, K., Liebman, M. N., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020177 · Cited by 3,397
A multigenic program mediating breast cancer metastasis to bone
Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Käkönen, S.-M., Cordon‐Cardo, C., Guise, T. A., & Massagué, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00132-6 · Cited by 2,605
Flagged first, then by citations
1 of the 102 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Darash-Yahana, M. et al. Human prostate cancer growth, vascularisation and metastasis is stimulated via high expression levels of the chemokine receptor CXCR4. Proc. Am. Assoc. Cancer Res. 44, 789 (2003).
Cited by
Sorted by citations
Items 801–900 of 1,000
Qing, R., Han, Q., Skuhersky, M., Chung, H., Badr, M. A., Schubert, T. E. O., & Zhang, S. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1909026116 · Cited by 54
Leveraging macrophages for cancer theranostics
Liu, L., Li, H., Wang, J., Zhang, J., Liang, X., Guo, W., & Gu, Z. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114136 · Cited by 53
Yao, X., Qi, L., Chen, X., Du, J., Zhang, Z., & Liu, S. (2013) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2012.12.006 · Cited by 53
Ziarek, J. J., Getschman, A. E., Butler, S. J., Taleski, D., Stephens, B. S., Kufareva, I., Handel, T. M., Payne, R. J., & Volkman, B. F. (2013) · ACS Chemical Biology · doi:10.1021/cb400274z · Cited by 53
Elucidating a Key Component of Cancer Metastasis: CXCL12 (SDF-1α) Binding to CXCR4
Tamamis, P., & Floudas, C. A. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci500069y · Cited by 53
Building Cell Selectivity into CPP-Mediated Strategies
Martín, I., Teixidò, M., & Giralt, E. (2010) · Pharmaceuticals · doi:10.3390/ph3051456 · Cited by 53
GPCR Signaling Mediates Tumor Metastasis via PI3Kβ
Khalil, B. D., Hsueh, C., Cao, Y., Saab, W. F. A., Wang, Y., Condeelis, J. S., Bresnick, A. R., & Backer, J. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1675 · Cited by 54
Cellular microenvironment modulates the galvanotaxis of brain tumor initiating cells
Huang, Y.-J., Hoffmann, G. A., Wheeler, B., Schiapparelli, P. V., Quiñones‐Hinojosa, A., & Searson, P. C. (2016) · Scientific Reports · doi:10.1038/srep21583 · Cited by 53
Rasti, A., Abolhasani, M., Zanjani, L. S., Asgari, M., Mehrazma, M., & Madjd, Z. (2016) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-016-2239-8 · Cited by 54
Pathophysiology of bone metastases from solid malignancies
Clézardin, P. (2017) · Joint Bone Spine · doi:10.1016/j.jbspin.2017.05.006 · Cited by 53
Morimoto‐Kamata, R., & Yui, S. (2017) · Cancer Science · doi:10.1111/cas.13286 · Cited by 54
Ma, J., Sun, X., Su, H., Chen, Q., Guo, T., Li, Y., Chen, X.-C., Guo, J., Gong, Z., Zhao, X., et al. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i28.5167 · Cited by 53
Feo, D. D., Merlini, A., Brambilla, E., Ottoboni, L., Laterza, C., Menon, R., Srinivasan, S., Farina, C., Manteiga, J. M. G., Butti, E., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92387 · Cited by 54
Prognostic significance of CXCL5 expression in cancer patients: a meta-analysis
Hu, B., Fan, H., Lv, X., Chen, S., & Shao, Z. (2018) · Cancer Cell International · doi:10.1186/s12935-018-0562-7 · Cited by 54
Grigorakaki, C., Morceau, F., Chateauvieux, S., Dicato, M. A., & Diederich, M. F. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.03.030 · Cited by 57
Chemokine Receptor CCR7 Expression Correlates with Lymph Node Metastasis in Pancreatic Cancer
Nakata, B., Fukunaga, S., Noda, E., Amano, R., Yamada, N., & Hirakawa, K. (2008) · Oncology · doi:10.1159/000139126 · Cited by 53
Angiogenesis as an immunopharmacologic target in inflammation and cancer
Bian, X. W., Chen, J. H., Jiang, X. F., Bai, J. S., Wang, Q. L., & Zhang, X. (2004) · International Immunopharmacology · doi:10.1016/j.intimp.2004.07.017 · Cited by 53
Lin, B.-R., Chang, C.-C., Chen, L.-R., Wu, M.-H., Wang, M.-Y., Kuo, I.-H., Chu, C.-Y., Chang, K.-J., Lee, P.-H., Chen, W.-J., et al. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0289 · Cited by 51
Macrophages, Neutrophils, and Cancer: A Double Edged Sword
Mantovani, A. (2014) · New Journal of Science · doi:10.1155/2014/271940 · Cited by 55
Computational Intelligence for Medical Imaging Simulations
Chang, V. I. C. (2017) · Journal of Medical Systems · doi:10.1007/s10916-017-0861-x · Cited by 52
Chemokines orchestrate tumor cells and the microenvironment to achieve metastatic heterogeneity
Saxena, S., & Singh, R. K. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-09970-6 · Cited by 54
Bose, S., Saha, P., Chatterjee, B., & Srivastava, A. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.03.028 · Cited by 52
Yang, Y., Wang, Y., Ahn, J., Kim, B., & Choi, J. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113474 · Cited by 52
Opfermann, P. L., Derhaschnig, U., Felli, A., Wenisch, J. M., Santer, D., Zuckermann, A. O., Dworschak, M., Jilma, B., & Steinlechner, B. (2014) · Clinical & Experimental Immunology · doi:10.1111/cei.12488 · Cited by 52
Roles of CXCL8 in squamous cell carcinoma proliferation and migration
Christofakis, E. P., Miyazaki, H., Rubink, D. S., & Yeudall, W. A. (2008) · Oral Oncology · doi:10.1016/j.oraloncology.2007.12.002 · Cited by 52
Mishra, N. C., Rir-sima-ah, J., Grotendorst, G. R., Langley, R. J., Singh, S. P., Gundavarapu, S., Weber, W., Peña-Philippides, J. C., Duncan, M. R., & Sopori, M. L. (2012) · International Immunopharmacology · doi:10.1016/j.intimp.2012.03.010 · Cited by 55
Epigenetics Underpinning the Regulation of the CXC (ELR+) Chemokines in Non-Small Cell Lung Cancer
Baird, A., Gray, S. G., & O'Byrne, K. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0014593 · Cited by 52
The role of cytokines in acute myeloid leukemia: A systematic review
Kupsa, T., Horáček, J. M., & Jebavý, L. (2012) · Biomedical Papers · doi:10.5507/bp.2012.108 · Cited by 50
Chen, J., Lan, T., Zhang, W., Dong, L., Kang, N., Zhang, S., Fu, M., Liu, B., Liu, K., & Zhan, Q. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-1062 · Cited by 52
Roles of Tristetraprolin in Tumorigenesis
Park, J., Lee, T.-H., & Kang, T. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113384 · Cited by 51
Ishida, Y., Kuninaka, Y., Yamamoto, Y., Nosaka, M., Kimura, A., Furukawa, F., Mukaida, N., & Kondo, T. (2020) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2020.02.023 · Cited by 52
Differential Expression of Chemokine Receptors on Uveal Melanoma Cells and Their Metastases
Li, H., ALIZADEH, H. M., & Niederkorn, J. Y. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-1035 · Cited by 54
Mimeault, M., & Batra, S. K. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9052-4 · Cited by 52
Liu, Y., Wang, B., Wang, J., Wan, W.-Z., Sun, R., Zhao, Y.-L., & Zhang, N. (2009) · Lung Cancer · doi:10.1016/j.lungcan.2008.05.010 · Cited by 47
Qi, Y., Li, Y., Man, X., Sui, H., Zhao, X., Zhang, P., Qu, X., Zhang, H., Wang, B., Li, J., et al. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29353 · Cited by 53
An emerging paradigm of CXCL12 involvement in the metastatic cascade
Anastasiadou, D. P., Quesnel, A., Duran, C. L., Filippou, P. S., & Karagiannis, G. S. (2023) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2023.10.003 · Cited by 56
Chen, L., Huang, Z., Yao, G., Lyu, X., Li, J., Hu, X., Cai, Y., Li, W., Li, X., & Ye, C. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0521-1 · Cited by 51
CD117+ cells in the circulation are predictive of advanced prostate cancer
Kerr, B. A., Miocinovic, R., Smith, A. K., West, X. Z., Watts, K. E., Alzayed, A. W., Klink, J. C., Mir, M. C., Sturey, T., Hansel, D. E., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2796 · Cited by 51
ADAM‐mediated amphiregulin shedding and EGFR transactivation
Kasina, S., Scherle, P., Hall, C. L., & Macoska, J. A. (2009) · Cell Proliferation · doi:10.1111/j.1365-2184.2009.00645.x · Cited by 51
Pan, Y., Smithson, L. J., Ma, Y., Hambardzumyan, D., & Gutmann, D. H. (2017) · Oncotarget · doi:10.18632/oncotarget.16516 · Cited by 51
English, E. J., Wedemeyer, S. A., & Marchese, A. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.001872 · Cited by 53
Cittera, E., Leidi, M., Buracchi, C., Pasqualini, F., Sozzani, S., Vecchi, A., Waterfield, J. D., Introna, M., & Golay, J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.10.6616 · Cited by 51
1,2,3,4-Tetrahydroisoquinoline (THIQ) as privileged scaffold for anticancer de novo drug design
Faheem, F., Kumar, B. K., Sekhar, K. V. G. C., Chander, S., Kunjiappan, S., & Murugesan, S. (2021) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2021.1916464 · Cited by 52
Kannan, S., Murugan, A. K., Balasubramanian, S., Munirajan, A. K., & Alzahrani, A. S. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115090 · Cited by 50
MCP-1 promotes invasion and adhesion of human ovarian cancer cells.
Furukawa, S., Soeda, S., Kiko, Y., Suzuki, O., Hashimoto, Y., Watanabe, T., Nishiyama, H., Tasaki, K., Hojo, H., Abe, M., et al. (2013) · PubMed · Cited by 50
p53-dependent expression of CXCR5 chemokine receptor in MCF-7 breast cancer cells
Mitkin, N. A., Hook, C., Schwartz, A. M., Biswas, S., Кочетков, Д. В., Muratova, A. M., Afanasyeva, M., Kravchenko, J. E., Bhattacharyya, A., & Kuprash, D. V. (2015) · Scientific Reports · doi:10.1038/srep09330 · Cited by 49
Otero, C., Eisele, P. S., Schaeuble, K., Groettrup, M., & Legler, D. F. (2008) · Journal of Cell Science · doi:10.1242/jcs.029074 · Cited by 50
Yeh, W., Lu, D., Liou, H., & Fu, W. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22746 · Cited by 53
Kyte, J. A., Trachsel, S., Risberg, B., Straten, P. T., Lislerud, K., & Gaudernack, G. (2009) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-009-0670-2 · Cited by 50
CXC Receptor and Chemokine Expression in Human Meningioma
Barbieri, F., Bajetto, A., Porcile, C., Pattarozzi, A., Massa, A., Lunardi, G., Zona, G., Dorcaratto, A., Ravetti, J. L., Spaziante, R., et al. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1378.037 · Cited by 50
Prognostic impact of CXCR4 and CXCR7 expression in pancreatic adenocarcinoma
Gebauer, F., Tachezy, M., Effenberger, K. E., von Loga, K., Zander, H., Marx, A., Kaifi, J. T., Sauter, G., Izbicki, J. R., & Bockhorn, M. (2011) · Journal of Surgical Oncology · doi:10.1002/jso.21957 · Cited by 50
Steinberg, M., & Silva, M. J. (2010) · Clinical Therapeutics · doi:10.1016/j.clinthera.2010.05.007 · Cited by 50
Tumor Microenvironment and Angiogenic Blood Vessels Dual-Targeting for Enhanced Anti-Glioma Therapy
Hu, Q., Kang, T., Feng, J., Zhu, Q., Jiang, T., Yao, J., Jiang, X., & Chen, J. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b08239 · Cited by 50
Deutsch, A. J. A., Aigelsreiter, A., Steinbauer, E., Frühwirth, M., Kerl, H., Beham‐Schmid, C., Schaider, H., & Neumeister, P. (2008) · The Journal of Pathology · doi:10.1002/path.2372 · Cited by 50
Nuclear PFKP promotes CXCR4-dependent infiltration by T cell acute lymphoblastic leukemia
Gao, X., Qin, S., Wu, Y., Chu, C., Jiang, B., Johnson, R. H., Kuang, D., Zhang, J., Wang, X., Mehta, A. S., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci143119 · Cited by 48
Roles of RNA-binding proteins in immune diseases and cancer
Hashimoto, S., & Kishimoto, T. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.03.017 · Cited by 49
The Role of TLR and Chemokine in Wear Particle-Induced Aseptic Loosening
Gu, Q., Shi, Q., & Yang, H. (2012) · BioMed Research International · doi:10.1155/2012/596870 · Cited by 50
CCR5 blockage by maraviroc induces cytotoxic and apoptotic effects in colorectal cancer cells
Pervaiz, A., Ansari, S. S., Berger, M. R., & Adwan, H. (2015) · Medical Oncology · doi:10.1007/s12032-015-0607-x · Cited by 49
Hepatocyte growth factor in invasive growth of carcinomas
Desiderio, M. A. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7050-x · Cited by 49
Stress-Adaptive Response in Ovarian Cancer Drug Resistance
Amoroso, M. R., Matassa, D. S., Agliarulo, I., Avolio, R., Maddalena, F., Condelli, V., Landriscina, M., & Esposito, F. (2017) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2017.01.004 · Cited by 50
Li, Z., Liu, J., Li, L., Shao, S., Wu, J., Bian, L., & He, Y. (2017) · Oncology Reports · doi:10.3892/or.2017.6169 · Cited by 49
CXCL-13 Regulates Resistance to 5-Fluorouracil in Colorectal Cancer
Zhang, G., Luo, X., Zhang, W., Chen, E., Xu, J., Wang, F., Cao, G., Ju, Z., Jin, D., Huang, X., et al. (2019) · Cancer Research and Treatment · doi:10.4143/crt.2019.593 · Cited by 48
Effective Treatments for Bladder Cancer Affecting CXCL9/CXCL10/CXCL11/ CXCR3 Axis: A Review
Nazari, A., Ahmadi, Z., Hassanshahi, G., Abbasifard, M., Taghipour, Z., Falahati‐pour, S. K., & Khorramdelazad, H. (2020) · Oman Medical Journal · doi:10.5001/omj.2020.21 · Cited by 49
Kurmi, B. D., Patel, P., Paliwal, R., & Paliwal, S. R. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101682 · Cited by 51
Ejaeidi, A. A., Craft, B. S., Puneky, L. V., Lewis, R. E., & Cruse, J. M. (2015) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2015.06.002 · Cited by 49
Colorectal Cancer: The Contribution of CXCL12 and Its Receptors CXCR4 and CXCR7
Goïta, A. A., & Guénot, D. (2022) · Cancers · doi:10.3390/cancers14071810 · Cited by 52
Prospects for targeting ACKR1 in cancer and other diseases
Crawford, K. S., & Volkman, B. F. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1111960 · Cited by 52
Chemokine receptor CCR6 as a prognostic factor after hepatic resection for hepatocellular carcinoma
Uchida, H., Iwashita, Y., Sasaki, A., Shibata, K., Matsumoto, T., Ohta, M., & Kitano, S. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2005.04157.x · Cited by 48
Immunological milieu in mycosis fungoides and S ézary syndrome
Miyagaki, T., & Sugaya, M. (2014) · The Journal of Dermatology · doi:10.1111/1346-8138.12305 · Cited by 49
Ashley, R. L., Antoniazzi, A. Q., Anthony, R. V., & Hansen, T. R. (2011) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-9-148 · Cited by 48
CXCL14 antagonizes the CXCL12-CXCR4 signaling axis
Hara, T., & Tanegashima, K. (2014) · BioMolecular Concepts · doi:10.1515/bmc-2014-0007 · Cited by 48
Lansley, S. M., Cheah, H. M., della Vergiliana, J. F. V., Chakera, A., & Lee, G. (2014) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2014-0017oc · Cited by 48
Meijer, J. M., Ogink, J., Kreike, B., Nuyten, D. S. A., de Visser, K. E., & Roos, E. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0482 · Cited by 48
RetractedCXCL12 Does Not Attract CXCR4+ Human Metastatic Neuroblastoma Cells: Clinical Implications
Airoldi, I., Raffaghello, L., Piovan, E., Cocco, C., Carlini, B., Amadori, A., Corrias, M. V., & Pistoia, V. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1376 · Cited by 48
Divella, R., Daniele, A., Savino, E., Palma, F., Bellizzi, A., Giotta, F., SIMONE, G. D., Lioce, M., Quaranta, M., Paradiso, A., et al. (2013) · PubMed · Cited by 47
Stronach, E. A., Cunnea, P., Turner, C. J., Güney, T. G., Aiyappa‐Maudsley, R., Jeyapalan, S., de Sousa, C. H., Browne, A. L., Magdy, N., Studd, J. B., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3415 · Cited by 47
Chen, Z.-Y., He, W., Peng, L., Jia, W., Guo, R., Xia, L., & Qian, C. (2014) · International Journal of Cancer · doi:10.1002/ijc.29017 · Cited by 48
Zhi, Y., Lu, H., Duan, Y., Sun, W.-S. W., Guan, G., Dong, Q., & Yang, C.-M. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.2032 · Cited by 47
Ok, S., Kim, S., Kim, C., Nam, D., Shim, B. S., Kim, S., Ahn, K. S., Choi, S., & Ahn, K. S. (2012) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2012.654494 · Cited by 47
Type I interferons inhibit the generation of tumor-associated macrophages
U’Ren, L., Guth, A., Kamstock, D. A., & DOW, S. W. (2009) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-009-0776-6 · Cited by 47
USP18 is crucial for IFN-γ-mediated inhibition of B16 melanoma tumorigenesis and antitumor immunity
Hong, B., Li, H., Lu, Y., Zhang, M., Zheng, Y., Qian, J., & Yi, Q. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-132 · Cited by 47
Kanda, K., Komekado, H., Sawabu, T., Ishizu, S., Nakanishi, Y., Nakatsuji, M., Akitake, R., Ohno, M., Hiraoka, Y., Kawada, M., et al. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201200216 · Cited by 47
Bacterial chemotaxis on SlipChip
Shen, C., Xu, P., Huang, Z., Cai, D., Liu, S., & Du, W. (2014) · Lab on a Chip · doi:10.1039/c4lc00213j · Cited by 48
Regulation of epithelial-mesenchymal transition by tumor-associated macrophages in cancer.
Zhang, J., Yao, H., Song, G., Liao, X., Xian, Y., & Li, W. (2015) · Europe PMC (PubMed Central) · Cited by 48
Mesenchymal stem cells: From stem cells to sarcomas
Lye, K. L., Nordin, N., Vidyadaran, S., & Thilakavathy, K. (2016) · Cell Biology International · doi:10.1002/cbin.10603 · Cited by 50
Kohnz, R. A., Roberts, L. S., DeTomaso, D., Bideyan, L., Yan, P., Bandyopadhyay, S., Goga, A., Yosef, N., & Nomura, D. K. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.6b00433 · Cited by 47
Gatla, H. R., Zou, Y., Uddin, M. M., Singha, B., Bu, P., Vančura, A., & Vancurova, I. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.771014 · Cited by 47
Rafat, M., Aguilera, T. A., Vilalta, M., Bronsart, L. L., Soto, L. A. C., von Eyben, R., Golla, M. A., Ahrari, Y., Melemenidis, S., Afghahi, A., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3623 · Cited by 49
Yunger, S., El, A. B., Zeltzer, L., Fridman, E., Raviv, G., Laufer, M., Schachter, J., Markel, G., Itzhaki, O., & Besser, M. J. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1672494 · Cited by 48
Latest update on chemokine receptors as therapeutic targets
Lai, W. Y., & Müeller, A. (2021) · Biochemical Society Transactions · doi:10.1042/bst20201114 · Cited by 50
Filimon, A., Preda, I. A., Boloca, A. F., & Negroiu, G. (2021) · Cells · doi:10.3390/cells11010120 · Cited by 51
ROSENKILDE, M. M., Smit, M. J., & Waldhoer, M. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707660 · Cited by 49
Kuzuhara, T., Suganuma, M., Kurusu, M., & Fujiki, H. (2006) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-006-0169-6 · Cited by 47
Role of stromal cell-derived factor 1 (SDF1/CXCL12) in regulating anterior pituitary function
Barbieri, F., Bajetto, A., Porcile, C., Pattarozzi, A., Schettini, G., & Florio, T. (2006) · Journal of Molecular Endocrinology · doi:10.1677/jme-06-0014 · Cited by 47
GROα promotes invasion of colorectal cancer cells
Fukui (2010) · Oncology Reports · doi:10.3892/or_00001008 · Cited by 47
Chu, C., Cha, S.-T., Lin, W.-C., Lu, P., Tan, C., Chang, C.-C., Lin, B.-R., Jee, S., & Kuo, M. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn228 · Cited by 47
Hepatocyte growth factor enhances CXCR4 expression favoring breast cancer cell invasiveness
Matteucci, E., Locati, M., & Desiderio, M. A. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.07.008 · Cited by 47
Najafi, A., Keykhaee, M., Khorramdelazad, H., Karimi, M. Y., Samimi, L. N., Aghamohamadi, N., Karimi, M., Falak, R., & Khoobi, M. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113483 · Cited by 48
Immune evasion in esophageal squamous cell cancer: From the perspective of tumor microenvironment
Li, R., Huang, B. Q., Tian, H., & Sun, Z. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2022.1096717 · Cited by 47
SDF-1/CXCR7 Axis Enhances Ovarian Cancer Cell Invasion by MMP-9 Expression Through p38 MAPK Pathway
Yu, Y., Li, H., Xue, B., Jiang, X., Huang, K., Ge, J., Zhang, H., & Chen, B. (2014) · DNA and Cell Biology · doi:10.1089/dna.2013.2289 · Cited by 46
Metadata
- Authors
- Balkwill, F.
- Venue
- Nature Reviews Cancer
- Published
- 2004-07
- Volume
- 4
- Issue
- 7
- Pages
- 540-550
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1986986419
- Cited by
- 2,343
- References
- 102
- Citations by year
- 2026: 31 · 2025: 45 · 2024: 57 · 2023: 82 · 2022: 112 · 2021: 132 · 2020: 122 · 2019: 84 · 2018: 131 · 2017: 127 · 2016: 134 · 2015: 133 · 2014: 152 · 2013: 119 · 2012: 135
- FWCI
- 9.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- chemokines, chemokine receptors, carcinogenesis, metastasis, tumor-host interaction, metastatic potential, site-specific metastasis, chemokine receptor antagonists, inflammation, autoimmune disease, cancer therapy
- MeSH terms
- Animals, Antineoplastic Agents, Autoimmune Diseases, Chemotaxis, Leukocyte, Humans, Inflammation, Macrophage Activation, Mice, Nude, Models, Biological, Neoplasm Invasiveness, Neoplasm Metastasis, Neoplasm Proteins, Neoplasms, Lymphocytes, Tumor-Infiltrating, Chemokines, Receptors, Chemokine, Xenograft Model Antitumor Assays, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review